Stoneridge Investment Partners LLC Biomarin Pharmaceutical Inc Transaction History

Stoneridge Investment Partners LLC

  • $269 Million
  • Q3 2024

A detailed history of Stoneridge Investment Partners LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Stoneridge Investment Partners LLC holds 4,190 shares of BMRN stock, worth $265,729. This represents 0.11% of its overall portfolio holdings.

Number of Shares
4,190
Holding current value
$265,729
% of portfolio
0.11%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
BUY
$69.02 - $93.84 $289,193 - $393,189
4,190 New
4,190 $295,000
Q4 2022

Feb 06, 2023
BUY
$80.93 - $108.63 $113,221 - $151,973
1,399 Added 47.55%
4,341 $449,000
Q3 2022

Oct 31, 2022
SELL
$82.16 - $96.94 $524,838 - $619,252
-6,388 Reduced 68.47%
2,942 $249,000
Q1 2022

Apr 26, 2022
BUY
$74.28 - $92.69 $693,032 - $864,797
9,330 New
9,330 $719,000
Q4 2021

Feb 02, 2022
SELL
$71.72 - $91.47 $304,164 - $387,924
-4,241 Closed
0 $0
Q3 2021

Nov 03, 2021
BUY
$74.77 - $85.47 $110,285 - $126,068
1,475 Added 53.33%
4,241 $328,000
Q2 2021

Aug 04, 2021
SELL
$75.51 - $84.79 $234,081 - $262,849
-3,100 Reduced 52.85%
2,766 $231,000
Q1 2021

Apr 30, 2021
BUY
$74.73 - $90.69 $438,366 - $531,987
5,866 New
5,866 $443,000
Q4 2020

Feb 02, 2021
SELL
$72.61 - $90.2 $207,737 - $258,062
-2,861 Closed
0 $0
Q3 2020

Oct 28, 2020
BUY
$71.87 - $131.03 $205,620 - $374,876
2,861 New
2,861 $218,000

Others Institutions Holding BMRN

# of Institutions
635
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Stoneridge Investment Partners LLC Portfolio

Follow Stoneridge Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stoneridge Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stoneridge Investment Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email